Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.61M P/E - EPS this Y -5.50% Ern Qtrly Grth -
Income -20.18M Forward P/E -0.89 EPS next Y 8.30% 50D Avg Chg -8.00%
Sales 226k PEG - EPS past 5Y - 200D Avg Chg 12.00%
Dividend N/A Price/Book 0.94 EPS next 5Y - 52W High Chg -32.00%
Recommedations 1.70 Quick Ratio 2.61 Shares Outstanding 21M 52W Low Chg 66.00%
Insider Own 0.78% ROA -38.07% Shares Float 20.84M Beta 1.35
Inst Own 7.95% ROE -84.30% Shares Shorted/Prior 20.70K/31.06K Price 1.03
Gross Margin 100.00% Profit Margin - Avg. Volume 90,809 Target Price 8.33
Oper. Margin -8,928.07% Earnings Date Mar 28 Volume 26,726 Change -1.44%
About Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. It has two clinical-stage programs, including narazaciclib, a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa study for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company also conducting a Phase II investigator-initiated study with rigosertib monotherapy in patients with advanced/metastatic squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa. It has a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib in China. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Onconova Therapeutics, Inc. News
03/09/24 We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully
03/08/24 Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
12/12/23 Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
12/08/23 Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
11/28/23 Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
11/16/23 Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
11/14/23 Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
11/07/23 Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
11/02/23 Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL
10/24/23 Onconova Expands Leadership Team with Two Key Appointments
10/19/23 Promising Preclinical Narazaciclib Data Presented at MCL Meeting
10/12/23 Encouraging Rigosertib Data Presented at EADV as Late Breaker
09/28/23 Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
09/06/23 Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
08/13/23 Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript
08/11/23 Q2 2023 Onconova Therapeutics Inc Earnings Call
08/10/23 Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
08/03/23 Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023
07/17/23 Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
06/14/23 Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma
ONTX Chatroom

User Image StormTripper75 Posted - 5 hours ago

$ONTX have a read at SBFM 10K filing on their website as a pdf 🚀

User Image PlannedTrading101 Posted - 13 hours ago

$ONTX send it! Still here 2.50 or nothing

User Image Vickyoko Posted - 16 hours ago

$APDN $OCGN $ONTX $ATOS

User Image Vonheimler67 Posted - 17 hours ago

$ONTX we getting compliance soon?

User Image MKRReformed Posted - 17 hours ago

$izea $ontx moving well for us 💪🏻

User Image rdcool90 Posted - 6 days ago

$ONTX what is it doing? Not ready to RS again?

User Image toughguy45 Posted - 1 week ago

$ONTX I’ve made so many benjamins shorting this piece of shit for the last few years. This be the gift that keeps giving

User Image Smmj Posted - 1 week ago

$ONTX str8 joke!!! Monopoly $. Smh haven’t budged since 2017 no green just r/s 😢

User Image free2dream Posted - 1 week ago

$ONTX in 2013 this was $70,000 ! what a fucking criminal enterprise . Fruchtman is a joke , the hole company is a joke.

User Image General_Stock Posted - 1 week ago

$ONTX 👀

User Image TristanKnowsIt Posted - 1 week ago

$ONTX Going up hopefully

User Image Trollblocker Posted - 1 week ago

$ONTX I had really high hopes for Oncosec but now I’m starting to have my doubts. Change my mind .

User Image RazorETC_F150Lightning Posted - 2 weeks ago

$ONTX $11 when?

User Image Vonheimler67 Posted - 2 weeks ago

$ONTX look at CLDX over last 4 years.......ONTX has some of same people involved....here's to hoping for a similar run

User Image Trollblocker Posted - 2 weeks ago

$ONTX

User Image jacksparo Posted - 2 weeks ago

$ONTX The Magic Micro cap list November 2023 copy! A lot of Money has been made since then

User Image Smmj Posted - 2 weeks ago

$ONTX

User Image Trollblocker Posted - 2 weeks ago

$ONTX Rigosertib is going to take us to $10

User Image RollingDollar Posted - 2 weeks ago

$ONTX

User Image RazorETC_F150Lightning Posted - 2 weeks ago

$ONTX a dollar 🥲

User Image free2dream Posted - 2 weeks ago

$ONTX $ONTX $CARA $XBI $LABU mean reversion, a lot more upside , especially after SOX rolls over

User Image Stock_Titan Posted - 2 weeks ago

$ONTX Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024 https://www.stocktitan.net/news/ONTX/onconova-therapeutics-rigosertib-poster-selected-for-aacr-3hc7dendyz25.html

User Image benjkohl85 Posted - 3 weeks ago

$CRDF $ONTX $IBRX $ABVC

User Image Guinness_007 Posted - 3 weeks ago

$CRDF $ONTX $IBRX $ABVC

User Image jacksparo Posted - 3 weeks ago

$CRDF The stock has entered a bullish zone after the earning and it is heading that way most likely for another few weeks. $ONTX Got a good gain here from my list last December. $IBRX Just two weeks ago or less made a great trade here with my team I am still holding some of this for further target. $ABVC It is heating up again let us see!

User Image PlannedTrading101 Posted - 3 weeks ago

$ONTX patience.

User Image Trollblocker Posted - 3 weeks ago

$ONTX

User Image PlannedTrading101 Posted - 3 weeks ago

$ONTX 2.50

User Image RollingDollar Posted - 3 weeks ago

$ONTX

User Image RazorETC_F150Lightning Posted - 3 weeks ago

$ONTX Give three fitty

Analyst Ratings
HC Wainwright & Co. Buy Oct 12, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Jun 14, 23
HC Wainwright & Co. Buy Jun 6, 23
HC Wainwright & Co. Buy May 25, 23
HC Wainwright & Co. Buy May 16, 23
HC Wainwright & Co. Buy Apr 21, 23
Ladenburg Thalmann Buy Mar 1, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
OLER ABRAHAM N. SVP Corp Dev & Gen C.. SVP Corp Dev & Gen Counsel Jan 28 Buy 1.67 1,500 2,505 24,514 01/31/22
OLER ABRAHAM N. SVP Corp Dev & Gen C.. SVP Corp Dev & Gen Counsel Jan 21 Buy 2.02 1,500 3,030 23,014 01/24/22
OLER ABRAHAM N. SVP CORP DEV & GEN C.. SVP CORP DEV & GEN COUNSEL Jan 14 Buy 2.20 1,500 3,300 21,514 01/18/22
OLER ABRAHAM N. SVP Corp Dev & Gen C.. SVP Corp Dev & Gen Counsel Jan 07 Buy 2.39 1,500 3,585 20,014 01/10/22